UBS Group AG Chief Executive Officer Sergio Ermotti said he will keep cutting headcount in the wake of the historic ...

UBS analyst Ashwani Verma increased the price target for Teva Pharmaceutical Industries Ltd (NYSE:TEVA) to $30 from the previous $28 while keeping a Buy rating on the shares. Verma highlighted Teva as ...

UBS Chief Executive Sergio Ermotti on Tuesday said it was currently premature for the Swiss bank to consider acquisitions as ...

A fifth of private deals in 2024 had some sustainability element, UBS' EMEA president told delegates at the World Economic ...

UBS Group AG Chief Executive Officer Sergio Ermotti said he’s looking at whether to follow Wall Street peers in abandoning a ...

And therefore I don't see rates coming down as fast as people believe," Ermotti told CNBC. Freshly inaugurated U.S. President ...

(Reuters) - UBS Group has halted accepting certain bonds and shares of Hong Kong property developer New World Development as ...

What do we expect from Budget 2025? UBS says changes in tax policy unlikely, especially for capital markets, expect measures ...

Retirement is often imagined as a carefree phase of life, filled with relaxation, hobbies, and quality time with loved ones. Rising interest in alternative investments — such as private equity, real ...

UBS raised the firm’s price target on AppLovin (APP) to $440 from $315 and keeps a Buy rating on the shares. The firm has more confidence in ...

Indian stocks have lost almost $500 billion in market value in the past month, with MSCI Inc.’s index for the nation marking ...

Investing.com -- Analysts at UBS Global Research have upgraded their target price for Rheinmetall (ETR: RHMG) to €805 from ...